These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 36050226)

  • 1. Blood-brain Barrier Damage is Pivotal for SARS-CoV-2 Infection to the Central Nervous System.
    Rodríguez-Morales J; Guartazaca-Guerrero S; Rizo-Téllez SA; Viurcos-Sanabria R; Barrón EV; Hernández-Valencia AF; Nava P; Escobedo G; Carrillo-Ruiz JD; Méndez-García LA
    Exp Neurobiol; 2022 Aug; 31(4):270-276. PubMed ID: 36050226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of the blood-brain barrier by COVID-19 and its implication in the permeation of drugs into the brain.
    Hernández-Parra H; Reyes-Hernández OD; Figueroa-González G; González-Del Carmen M; González-Torres M; Peña-Corona SI; Florán B; Cortés H; Leyva-Gómez G
    Front Cell Neurosci; 2023; 17():1125109. PubMed ID: 36998270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Levels of IL-8 and MCP-1 in Cerebrospinal Fluid of COVID-19 Patients with Cerebrovascular Disease.
    Guartazaca-Guerrero S; Rodríguez-Morales J; Rizo-Téllez SA; Solleiro-Villavicencio H; Hernández-Valencia AF; Carrillo-Ruiz JD; Escobedo G; Méndez-García LA
    Exp Neurobiol; 2021 Jun; 30(3):256-261. PubMed ID: 34230225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 and cognitive impairment: neuroinvasive and blood‒brain barrier dysfunction.
    Chen Y; Yang W; Chen F; Cui L
    J Neuroinflammation; 2022 Sep; 19(1):222. PubMed ID: 36071466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2.
    Krasemann S; Haferkamp U; Pfefferle S; Woo MS; Heinrich F; Schweizer M; Appelt-Menzel A; Cubukova A; Barenberg J; Leu J; Hartmann K; Thies E; Littau JL; Sepulveda-Falla D; Zhang L; Ton K; Liang Y; Matschke J; Ricklefs F; Sauvigny T; Sperhake J; Fitzek A; Gerhartl A; Brachner A; Geiger N; König EM; Bodem J; Franzenburg S; Franke A; Moese S; Müller FJ; Geisslinger G; Claussen C; Kannt A; Zaliani A; Gribbon P; Ondruschka B; Neuhaus W; Friese MA; Glatzel M; Pless O
    Stem Cell Reports; 2022 Feb; 17(2):307-320. PubMed ID: 35063125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Mechanisms of Proteins - Targets for SARS-CoV-2 (Review).
    Morgun AV; Salmin VV; Boytsova EB; Lopatina OL; Salmina AB
    Sovrem Tekhnologii Med; 2021; 12(6):98-108. PubMed ID: 34796023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microglia do not restrict SARS-CoV-2 replication following infection of the central nervous system of K18-hACE2 transgenic mice.
    Olivarria GM; Cheng Y; Furman S; Pachow C; Hohsfield LA; Smith-Geater C; Miramontes R; Wu J; Burns MS; Tsourmas KI; Stocksdale J; Manlapaz C; Yong WH; Teijaro J; Edwards R; Green KN; Thompson LM; Lane TE
    bioRxiv; 2021 Nov; ():. PubMed ID: 34816260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: Studies in 8 stuporous and comatose patients.
    Alexopoulos H; Magira E; Bitzogli K; Kafasi N; Vlachoyiannopoulos P; Tzioufas A; Kotanidou A; Dalakas MC
    Neurol Neuroimmunol Neuroinflamm; 2020 Nov; 7(6):. PubMed ID: 32978291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 Spike Protein Disrupts Blood-Brain Barrier Integrity via RhoA Activation.
    DeOre BJ; Tran KA; Andrews AM; Ramirez SH; Galie PA
    J Neuroimmune Pharmacol; 2021 Dec; 16(4):722-728. PubMed ID: 34687399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replication Kinetics, Cell Tropism, and Associated Immune Responses in SARS-CoV-2- and H5N1 Virus-Infected Human Induced Pluripotent Stem Cell-Derived Neural Models.
    Bauer L; Lendemeijer B; Leijten L; Embregts CWE; Rockx B; Kushner SA; de Vrij FMS; van Riel D
    mSphere; 2021 Jun; 6(3):e0027021. PubMed ID: 34160239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood-brain barrier in chronic relapsing experimental allergic encephalomyelitis: a correlative study between cerebrospinal fluid protein concentrations and tracer leakage in the central nervous system.
    Kitz K; Lassmann H; Karcher D; Lowenthal A
    Acta Neuropathol; 1984; 63(1):41-50. PubMed ID: 6730912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral microvascular complications associated with SARS-CoV-2 infection: How did it occur and how should it be treated?
    Omidian N; Mohammadi P; Sadeghalvad M; Mohammadi-Motlagh HR
    Biomed Pharmacother; 2022 Oct; 154():113534. PubMed ID: 35994816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral Infection of the Central Nervous System and Neuroinflammation Precede Blood-Brain Barrier Disruption during Japanese Encephalitis Virus Infection.
    Li F; Wang Y; Yu L; Cao S; Wang K; Yuan J; Wang C; Wang K; Cui M; Fu ZF
    J Virol; 2015 May; 89(10):5602-14. PubMed ID: 25762733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Relevance.
    Achar A; Ghosh C
    Cells; 2020 Oct; 9(11):. PubMed ID: 33120941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in vitro models of the human blood-brain barrier.
    Buzhdygan TP; DeOre BJ; Baldwin-Leclair A; McGary H; Razmpour R; Galie PA; Potula R; Andrews AM; Ramirez SH
    bioRxiv; 2020 Jun; ():. PubMed ID: 32587958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms.
    Zhou Z; Kang H; Li S; Zhao X
    J Neurol; 2020 Aug; 267(8):2179-2184. PubMed ID: 32458193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response and blood-brain barrier dysfunction during viral neuroinvasion.
    Chen Z; Li G
    Innate Immun; 2021 Feb; 27(2):109-117. PubMed ID: 32903111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction.
    Engelhardt B; Sorokin L
    Semin Immunopathol; 2009 Nov; 31(4):497-511. PubMed ID: 19779720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages.
    Pantazi I; Al-Qahtani AA; Alhamlan FS; Alothaid H; Matou-Nasri S; Sourvinos G; Vergadi E; Tsatsanis C
    Front Immunol; 2021; 12():683800. PubMed ID: 34248968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSF Biomarkers in Patients With COVID-19 and Neurologic Symptoms: A Case Series.
    Edén A; Kanberg N; Gostner J; Fuchs D; Hagberg L; Andersson LM; Lindh M; Price RW; Zetterberg H; Gisslén M
    Neurology; 2021 Jan; 96(2):e294-e300. PubMed ID: 33004602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.